Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Cerilliant
Mallinckrodt
Argus Health
Citi
Moodys
McKesson
AstraZeneca

Generated: November 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018321

« Back to Dashboard

NDA 018321 describes TECHNESCAN, which is a drug marketed by Mallinkrodt Nuclear, Draximage, and Mallinckrodt, and is included in six NDAs. It is available from one supplier. Additional details are available on the TECHNESCAN profile page.

The generic ingredient in TECHNESCAN is technetium tc-99m pyrophosphate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pyrophosphate kit profile page.
Summary for 018321
Tradename:TECHNESCAN
Applicant:Mallinkrodt Nuclear
Ingredient:technetium tc-99m oxidronate kit
Patents:0
Suppliers and Packaging for NDA: 018321
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-091 69945-091-20 5 VIAL in 1 CELLO PACK (69945-091-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-091 69945-091-40 30 VIAL in 1 CARTON (69945-091-40) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 018321

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinkrodt Nuclear TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
AstraZeneca
Julphar
Teva
Daiichi Sankyo
Healthtrust
Johnson and Johnson
Baxter
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.